Show simple item record

dc.contributor.authorSönmez, Alper
dc.contributor.authorHaymana,Cem
dc.contributor.authorBayram, Fahri
dc.contributor.authorSalman, Serpil
dc.contributor.authorDizdar, Oğuzhan Sıtkı
dc.contributor.authorGürkan, Eren
dc.contributor.authorÇarlıoğlu, Ayşe Kargılı
dc.contributor.authorBarçın, Cem
dc.contributor.authorSabuncu, Tevfik
dc.contributor.authorSatman, İlhan
dc.contributor.authorDemirbaş, Berrin
dc.date.accessioned2019-03-28T10:51:41Z
dc.date.available2019-03-28T10:51:41Z
dc.date.issued2018-12
dc.identifier.citationSonmez, A., Haymana, C., Bayram, F., Salman, S., Dizdar, O. S., Gurkan, E., ... & Guldiken, S. (2018). Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study). Diabetes research and clinical practice, 146, 138-147.en_US
dc.identifier.urihttps://doi.org/10.1016/j.diabres.2018.09.010
dc.identifier.urihttp://hdl.handle.net/20.500.11851/866
dc.description.abstractAIMS: Turkey has the highest prevalence of diabetes in Europe. It is therefore essential to know the overall cardiovascular risk and reveal the predictors of metabolic control in Turkish adults with diabetes mellitus. METHODS: A nationwide, multicenter survey consecutively enrolled patients who were under follow up for at least a year. Optimal control was defined as HbA1c < 7%, home arterial blood pressure (ABP) < 135/85 mmHg, or LDL-C < 100 mg/dL. Achieving all parameters indicated triple metabolic control. RESULTS: HbA1c levels of patients (n = 5211) were 8.6 ± 1.9% (71 ± 22 mmol/mol) and 7.7 ± 1.7% (61 ± 19 mmol/mol), in Type 1 and Type 2 diabetes, respectively. Glycemic control was achieved in 15.3% and 40.2%, and triple metabolic control was achieved in 5.5% and 10.1%, respectively. Only 1.5% of patients met all the criteria of being non-obese, non-smoker, exercising, and under triple metabolic control. Low education level was a significant predictor of poor glycemic control in both groups. CONCLUSIONS: Few patients with Type 2, and even fewer with Type 1 diabetes have optimal metabolic control in Turkey. TEMD study will provide evidence-based information to policy makers to focus more on the quality and sustainability of diabetes care in order to reduce the national burden of the disease.en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.diabres.2018.09.010en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectType 2 diabetesen_US
dc.subjectType 1 diabetesen_US
dc.subjectLDL-cholesterolen_US
dc.subjectHbA1cen_US
dc.subjectArterial blood pressureen_US
dc.titleTurkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study)en_US
dc.typearticleen_US
dc.relation.journalDiabetes Research and Clinical Practiceen_US
dc.contributor.departmentTOBB ETÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.identifier.volume146en_US
dc.identifier.startpage138en_US
dc.identifier.endpage147en_US
dc.identifier.wosWOS:000452704800016
dc.contributor.tobbetuauthorDemirbaş, Berrin
dc.contributor.YOKid258892
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record